COVID-19 mRNA vaccine-associated cerebral venous thrombosis: Rare adverse event or coincidence?
作者信息
Fan Bingwen Eugene, Ling Ryan Ruiyang, Ramanathan Kollengode, Leung Bernard Pui Lam, Lim Xin Rong, Chadachan Veerendra M, Thirugnanam Umapathi, Stegner David, Tu Tian Ming
机构信息
Department of Haematology, Tan Tock Seng Hospital, Singapore.
Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore.
出版信息
Am J Hematol. 2023 Jan;98(1):E4-E7. doi: 10.1002/ajh.26773. Epub 2022 Nov 10.
Abstract
摘要
相似文献
1
COVID-19 mRNA vaccine-associated cerebral venous thrombosis: Rare adverse event or coincidence?新型冠状病毒肺炎信使核糖核酸疫苗相关的脑静脉血栓形成：罕见不良事件还是巧合？
Am J Hematol. 2023 Jan;98(1):E4-E7. doi: 10.1002/ajh.26773. Epub 2022 Nov 10.
2
Vaccine-induced COVID-19 mimicry syndrome.疫苗诱导的 COVID-19 模拟综合征。
Elife. 2022 Jan 27;11:e74974. doi: 10.7554/eLife.74974.
3
Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19.新型冠状病毒肺炎疫苗接种后血小板减少伴发的脑静脉窦血栓形成
Crit Care. 2021 Apr 12;25(1):137. doi: 10.1186/s13054-021-03572-y.
4
Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.BNT162b2 mRNA新冠疫苗接种后发生脑静脉血栓形成：一个黑天鹅事件。
Am J Hematol. 2021 Sep 1;96(9):E357-E361. doi: 10.1002/ajh.26272. Epub 2021 Jun 26.
5
Cerebral Venous Sinus Thrombosis and Papilledema in Vaccine-Induced Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination.新型冠状病毒疫苗接种后疫苗诱导的血栓性血小板减少症中的脑静脉窦血栓形成和视乳头水肿
J Neuroophthalmol. 2023 Mar 1;43(1):e16-e18. doi: 10.1097/WNO.0000000000001753. Epub 2022 Dec 21.
6
Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis.新型冠状病毒疫苗接种背景下的脑静脉窦血栓形成：系统评价和荟萃分析。
J Neurol. 2022 Jul;269(7):3413-3419. doi: 10.1007/s00415-022-11101-2. Epub 2022 Apr 8.
7
Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.BNT162b2 mRNA SARS-CoV-2 疫苗接种后并发脑静脉血栓形成。
J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105906. doi: 10.1016/j.jstrokecerebrovasdis.2021.105906. Epub 2021 May 25.
8
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.美国人群中基于腺病毒载体的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种后及冠状病毒病（COVID-19）后发生的脑静脉窦血栓形成
J Am Coll Cardiol. 2021 Jul 27;78(4):408-411. doi: 10.1016/j.jacc.2021.06.001. Epub 2021 Jun 8.
9
Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?mRNA COVID-19 疫苗接种后并发脑静脉窦血栓形成伴蛛网膜下腔出血：这些报告仅仅是巧合吗？
Am J Case Rep. 2021 Sep 3;22:e933397. doi: 10.12659/AJCR.933397.
10
Cerebral venous thrombosis after COVID-19 vaccination: the role for endovascular treatment.新冠病毒疫苗接种后发生的脑静脉血栓形成：血管内治疗的作用
J Neurointerv Surg. 2022 Sep;14(9):849-850. doi: 10.1136/neurintsurg-2021-018516. Epub 2022 Feb 17.
引用本文的文献
1
Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19.风险效益分析，以评估mRNA新冠疫苗接种后及感染新冠病毒后发生血栓栓塞事件的风险。
NPJ Vaccines. 2024 Sep 13;9(1):166. doi: 10.1038/s41541-024-00960-7.
2
Carditis following COVID-19 vaccination: balancing the risks and benefits.新冠病毒疫苗接种后的心肌炎：权衡风险与益处
Lancet Reg Health West Pac. 2023 Jun;35:100765. doi: 10.1016/j.lanwpc.2023.100765. Epub 2023 Apr 12.
本文引用的文献
1
Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation.通过CLEC-2和糖蛋白IIb/IIIa依赖性血小板激活引发的暴发性脑静脉（窦）血栓形成。
Nat Cardiovasc Res. 2022 Feb;1(2):132-141. doi: 10.1038/s44161-021-00017-1. Epub 2022 Feb 10.
2
Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database.新冠病毒mRNA疫苗与脑静脉血栓形成的关联：基于世界卫生组织药物警戒数据库的不成比例性分析
Vaccines (Basel). 2022 May 18;10(5):799. doi: 10.3390/vaccines10050799.
3
Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.新加坡 SARS-CoV-2 感染与 mRNA SARS-CoV-2 疫苗接种后颅内静脉血栓形成的发生率。
JAMA Netw Open. 2022 Mar 1;5(3):e222940. doi: 10.1001/jamanetworkopen.2022.2940.
4
Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose.接种第二剂ChAdOx1 nCoV-19疫苗后因疫苗诱导的免疫性血栓性血小板减少症导致的脑静脉血栓形成
Blood. 2022 Apr 28;139(17):2720-2724. doi: 10.1182/blood.2021015329.
5
BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study.BNT162b2信使核糖核酸新冠疫苗不会导致内皮激活标志物上调或高凝状态：一项前瞻性单臂纵向研究。
Am J Hematol. 2022 Apr;97(4):E141-E144. doi: 10.1002/ajh.26462. Epub 2022 Jan 19.
6
Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England.ChAdOx1和BNT162b2新冠疫苗接种后不同时间段静脉血栓形成事件和血小板减少症的风险：英国一项全国队列研究
Lancet Reg Health Eur. 2022 Feb;13:100260. doi: 10.1016/j.lanepe.2021.100260. Epub 2021 Dec 13.
7
Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.新型冠状病毒疫苗接种后大脑静脉窦血栓形成的年龄分层风险。
Neurology. 2022 Feb 15;98(7):e759-e768. doi: 10.1212/WNL.0000000000013148. Epub 2021 Dec 17.
8
Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites.使用 EudraVigilance 数据库比较欧洲四种 COVID-19 疫苗的不良反应：不常见部位的血栓形成。
J Thromb Haemost. 2021 Oct;19(10):2554-2558. doi: 10.1111/jth.15493. Epub 2021 Aug 25.
9
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study.接种新冠病毒疫苗后无高凝状态：一项观察性初步研究。
Thromb Res. 2021 Sep;205:24-28. doi: 10.1016/j.thromres.2021.06.016. Epub 2021 Jun 25.
10
Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.BNT162b2 mRNA新冠疫苗接种后发生脑静脉血栓形成：一个黑天鹅事件。
Am J Hematol. 2021 Sep 1;96(9):E357-E361. doi: 10.1002/ajh.26272. Epub 2021 Jun 26.
Zotero 插件